Vitamin D3 Oral Solution 60000 IU

The product should be prescribed with caution to patients suffering from sarcoidosis, impairment of renal function, suffering from cardiac conditions like arteriosclerosis, in elderly patients on concomitant treatment with cardiac glycosides or diuretics and patients with a high tendency to calculus formation. In case of hypercalciuria or signs of impaired renal function the dose should be reduced or the treatment discontinued.

High dose of cholecalciferol can cause weakness, fatigue, sleepiness, headache, loss of appetite, dry mouth, metallic taste, nausea and vomiting. Vitamin D toxicity, including nephrocalcinosis/ renal failure, hypertension can occur with prolonged use of cholecalciferol, relatively low doses can produce toxicity in hypersensitive infants and children. Hypervitaminosis D is reversible upon discontinuation of treatment unless renal damage is severe.

Vitamin D3 60000 IU to be given once a week for a period of 8 weeks, followed by maintenance daily dose as directed by the physician.

The product is not recommended during pregnancy in patients without a vitamin D deficiency. Vitamin D3 passes into breast milk hence should be considered while giving additional vitamin D to the child.